Does DARATUMUMAB Cause Orthostatic hypotension? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Orthostatic hypotension have been filed in association with DARATUMUMAB (DARZALEX). This represents 0.2% of all adverse event reports for DARATUMUMAB.
61
Reports of Orthostatic hypotension with DARATUMUMAB
0.2%
of all DARATUMUMAB reports
7
Deaths
50
Hospitalizations
How Dangerous Is Orthostatic hypotension From DARATUMUMAB?
Of the 61 reports, 7 (11.5%) resulted in death, 50 (82.0%) required hospitalization, and 12 (19.7%) were considered life-threatening.
Is Orthostatic hypotension Listed in the Official Label?
Yes, Orthostatic hypotension is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Orthostatic hypotension?
FUROSEMIDE (1,442)
AMLODIPINE (1,379)
OXAZEPAM (714)
DILTIAZEM (678)
NITROGLYCERIN (673)
LEVOTHYROXINE (671)
OMEPRAZOLE (664)
AMITRIPTYLINE (647)
MORPHINE (646)
ROSUVASTATIN (641)
Which DARATUMUMAB Alternatives Have Lower Orthostatic hypotension Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE